Trial Profile
Effects of the orexin receptor antagonist suvorexant on respiration during sleep in healthy subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs Suvorexant (Primary)
- Indications Insomnia
- Focus Pharmacodynamics
- Sponsors Merck & Co
- 09 Nov 2015 New trial record